
Bransen Pharmaceuticals Private Limited
About Bransen Pharmaceuticals Private Limited
Data last updated:
Bransen Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It was incorporated on 16 June 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U46497DL2023PTC415702.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manmohan Singh Negi and Manju.
Its last annual general meeting (AGM) was held on 14 October 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No – F – 12/8 C 3rd Floor, Joga Bai Extn Okhla, New Delhi, Delhi, India – 110025.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.8 Lakh. For the same year it recorded a net profit of ₹8,326 (net margin 1.7%) and EBITDA of ₹16,187 (EBITDA margin 3.4%).
Company details
Contact details
Bransen Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressH.No – F – 12/8 C 3rd Floor, Joga Bai Extn Okhla, New Delhi, Delhi, India – 110025
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bransen Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bransen Pharmaceuticals Private Limited, buy the company report.
Financials of Bransen Pharmaceuticals Private Limited
FY 2024 filings availableBransen Pharmaceuticals Private Limited reported revenue of ₹4.8 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹16,187 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹8,326 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2023-24 |
|---|---|
| Profitability | |
| EBITDA Margin | 3.4% |
| Net Profit Margin | 1.7% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Bransen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bransen Pharmaceuticals Private Limited
Bransen Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manmohan Singh Negi | Director | 17 May 2024 | 2 Years 6 Months | Current |
| Manju | Director | 16 Jun 2023 | 3 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Bransen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bransen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Bransen Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Bransen Pharmaceuticals Private Limited has 4 board changes on record since 2023: 2 appointments and 2 cessations. The latest: Preeti Rani ceased to be Director on 18 May 2024.
Frequently asked questions
Bransen Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. It was incorporated on 16 June 2023 (3+ years old) and is registered under CIN U46497DL2023PTC415702.
Bransen Pharmaceuticals has 2 current directors:
- Manmohan Singh Negi - Director
- Manju - Director
The latest financial statements of Bransen Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 14 October 2024. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Bransen Pharmaceuticals is U46497DL2023PTC415702. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bransen Pharmaceuticals was incorporated on 16 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
Preeti Rani ceased to be Director on 18 May 2024. Sarika Malhotra ceased to be Director on 18 May 2024. Manmohan Singh Negi was appointed as Director on 17 May 2024. Bransen Pharmaceuticals has 4 board changes on record in total.
The registered office of Bransen Pharmaceuticals is at H.No – F – 128 C 3rd Floor, Joga Bai Extn Okhla, New Delhi, Delhi, India – 110025.
Bransen Pharmaceuticals can be reached at its registered office: H.No – F – 128 C 3rd Floor, Joga Bai Extn Okhla, New Delhi, Delhi, India – 110025.
Bransen Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.

